Title: Inhibition of prostaglandin H2 synthases by salicylate is dependent on the oxidative state of the enzymes.
Journal: The Journal of pharmacology and experimental therapeutics 20030201
16002-93-0
87864-20-8
826-18-6
28525-69-1
17920-83-1
76978-38-6
13178-12-6 | 5-(4-Bromophenyl)-1,3,4-thiadiazol-2-amine | AA000ZNR | MFCD00469706
13200-86-7 | N-Formyl-l-tyrosine | AA000ZZ1 | MFCD00021031
132209-79-1 | Ethyl 2-chloro-1,8-naphthyridine-3-carboxylate | AA0010AS | MFCD16653113
132470-28-1 | 1-(Benzyloxy)-3-(4-methoxyphenyl)benzene | AA0010NC | MFCD20529465
132715-69-6 | 2-Bromo-3-fluorobenzoic acid | AA0010YS | MFCD01569398
13291-89-9 | Acetic-2-13C acid, sodium salt (8CI,9CI) | AA0011AQ | MFCD30486415
1363360-02-4 | 7-Methyl-7-azaspiro[3.5]nonane-2-methanol | AA0011LC | MFCD00712154
13639-54-8 | β-D-Glucopyranose, 1-thio-, 2,3,4,6-tetraacetate 1-(O-ethyl carbonodithioate) | AA0011RP | MFCD08457771
1365272-56-5 | 3-(5-Fluoro-2-methoxyphenyl)benzonitrile | AA0011YM | MFCD21609600
136773-69-8 | 4-Chloro-7-fluoropyrrolo[1,2-a]quinoxaline | AA00129A | MFCD09835554
